238 related articles for article (PubMed ID: 8950064)
1. Pathologic consequences of increased angiotensin II activity.
Ferrario CM; Flack JM
Cardiovasc Drugs Ther; 1996 Nov; 10(5):511-8. PubMed ID: 8950064
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
Eberhardt RT; Kevak RM; Kang PM; Frishman WH
J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Velasquez MT
Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
[TBL] [Abstract][Full Text] [Related]
4. Rationale for the chemical development of angiotensin II receptor antagonists.
Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
6. [Angiotensin-II receptor blockers].
Metelitsa VI
Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
[No Abstract] [Full Text] [Related]
7. [Antagonists of angiotensin II receptor].
Karasek D; Adamski M; Grzeszczak W
Postepy Hig Med Dosw; 1996; 50(1):21-32. PubMed ID: 8778711
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
9. The diversified pharmacology of angiotensin II-receptor blockade.
Timmermans PB; Smith RD
Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
[TBL] [Abstract][Full Text] [Related]
10. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
Iyer SN; Katovich MJ
Am J Hypertens; 1996 Jul; 9(7):662-8. PubMed ID: 8806978
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
13. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.
Bauer JH; Reams GP
Arch Intern Med; 1995 Jul; 155(13):1361-8. PubMed ID: 7794084
[TBL] [Abstract][Full Text] [Related]
15. Losartan (Cozaar).
Baldinger S
Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
[No Abstract] [Full Text] [Related]
16. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
17. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
[TBL] [Abstract][Full Text] [Related]
18. Losartan: the first angiotensin receptor antagonist in clinical use.
Beevers DG
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
[No Abstract] [Full Text] [Related]
19. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
Wong PC; Hart SD; Duncia JV; Timmermans PB
Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
Robberecht W; Andries M; Denef C
Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
